Literature DB >> 24199212

Percutaneous liver biopsy practice patterns among Canadian hepatologists.

Mohammed Aljawad, Eric M Yoshida, Julia Uhanova, Paul Marotta, Natasha Chandok.   

Abstract

BACKGROUND: Percutaneous liver biopsy (PLB) is the standard procedure to obtain histological samples essential for the management of various liver diseases. While safe, many hepatologists no longer perform their own PLBs; the reasons for this practice shift are unknown.
OBJECTIVE: To describe the attitudes, practice patterns and barriers to PLB among hepatologists in Canada.
METHODS: A survey was distributed to all hepatologists in Canada.
RESULTS: Thirty-two of 40 (80%) hepatologists completed the survey; the majority of respondents were male (72%) and had been in practice for >5 years in an academic setting. Fifty-six per cent of hepatologists referred all PLBs to radiology, and only 19% of hepatologists reported performing their own PLBs most or all of the time. There were no sex differences nor were there differences based on years in practice. Fifty per cent of respondents who performed PLB routinely used ultrasound, and PLBs are performed in equal frequency in an ambulatory procedure area (50%) versus the endoscopy suite (36%). For almost one-half of hepatologists (47%), their performance of PLBs decreased in the past five years. The majority of respondents at an academic centre (75%) reported access to FibroScan (Echosens, France), and most estimated a resultant 25% to 50% reduction in the need for PLBs. Lack of resources, patient preference and suboptimal reimbursement were the most common reasons cited for not performing PLBs.
CONCLUSION: Most hepatologists in Canada do not perform PLBs to the extent that they did in the past, but refer to radiology. The reasons for this shift in practice include lack of resources, improved perception of safety and patient preference. Where available, FibroScan resulted in a perceived 25% to 50% reduction in required liver biopsies.

Entities:  

Mesh:

Year:  2013        PMID: 24199212      PMCID: PMC3816949          DOI: 10.1155/2013/429834

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  27 in total

1.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey.

Authors:  W Mayoral; J H Lewis
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  A survey of current liver biopsy practice patterns.

Authors:  Andrew J Muir; James F Trotter
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

3.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 4.  Liver biopsy in the mid-1990s: questions and answers.

Authors:  D J van Leeuwen; L Wilson; D R Crowe
Journal:  Semin Liver Dis       Date:  1995-11       Impact factor: 6.115

5.  Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.

Authors:  R Olsson; I Hägerstrand; U Broomé; A Danielsson; G Järnerot; L Lööf; H Prytz; B O Rydén; S Wallerstedt
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

7.  Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Authors:  Jérôme Boursier; Jean-Pierre Zarski; Victor de Ledinghen; Marie-Christine Rousselet; Nathalie Sturm; Brigitte Lebail; Isabelle Fouchard-Hubert; Yves Gallois; Frédéric Oberti; Sandrine Bertrais; Paul Calès
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

8.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frederic Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Journal:  Clin Chem       Date:  2004-06-10       Impact factor: 8.327

9.  Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists.

Authors:  Terence L Angtuaco; Sunil K Lal; Geraldine D Banaad-Omiotek; Syed S A Zaidi; Colin W Howden
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  7 in total

1.  Transient elastography in Canada: current state and future directions.

Authors:  Mohammed Aljawad; Sanjeev Sirpal; Eric M Yoshida; Natasha Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

2.  FibroScan® access in Canada: Time for reform, a call for universal access.

Authors:  Sergio M Borgia
Journal:  Can J Gastroenterol Hepatol       Date:  2015-05

3.  Why most hepatologists do not perform percutaneous liver biopsy. Re: Aljawad M, Yoshida EM, Uhanova J, Marotta P, Chandok N. Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol 2013;27:e31-34.

Authors:  Enver Zerem
Journal:  Can J Gastroenterol Hepatol       Date:  2014-02

4.  Out with the old and in with the new: hepatic fibrosis assessment in Canada.

Authors:  Natasha Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2014-01

5.  Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia.

Authors:  Victoria Yui-Min Kan; Vladimir Marquez Azalgara; Jo-Ann E Ford; W C Peter Kwan; Siegfried Roland Erb; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

Review 6.  Liver biopsy for assessment of chronic liver diseases: a synopsis.

Authors:  Aqib B Chowdhury; Kosha J Mehta
Journal:  Clin Exp Med       Date:  2022-02-22       Impact factor: 3.984

Review 7.  Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.

Authors:  K Thavorn; D Coyle
Journal:  Ont Health Technol Assess Ser       Date:  2015-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.